Abstract
The study evaluated the overall survival after AIDS diagnosis of 1,014 patients reported to the Italian AIDS Registry as resident in Tuscany, stratified by age, gender, year of diagnosis, HIV transmission category, initial AIDS-defining disease and CD4+ cells count. The study was a population-based survival analysis, carried out through Kaplan-Meier method (mean survival times -- MST --, 1, 2 and 3-year observed survival) and Cox models (crude and adjusted relative risk -- RR). The MST was 12.4 months for all cases, increasing from 4--7 months in 1985-- 1987 to 14 months in 1991--1992. The observed survival was 51.4% at the first year of follow-up, 28.4% at the second year and 14.5% at the third year. The multivariate analysis showed an independent prognostic effect of age, year of diagnosis, initial AIDS-defining disease and CD4+ cells count. The prognosis was worse in cases aged over 44 (reference: 25--29), diagnosed before 1988 (reference: 1991) and with wasting syndrome, toxoplasmosis, HIV encephalopaty or multiple diseases (reference: PCP alone); and better in cases with more than 100 CD4+ cells/mm3 (reference: ≤ 50 cells/mm3). The differences in gender and among HIV transmission categories disappeared after age-adjustment. The study confirmed, in an European population-based series, the poor long-term AIDS prognosis and, once AIDS has became clinically manifest, the prognostic value of some clinical and demographic variables.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Chang HG, Morse D, Noonan C, et al. Survival and mortality pattern of an acquired immunodeficiency syndrome (AIDS) cohort in New York State. Am J Epidemiol 1993; 138: 341–349.
Blum S, Singh T, Gibbon J, et al. Trends in survival among person with acquired immunodeficiency syndrome in New York City. Am J Epidemiol 1994; 139: 351–361.
Maden C, Hopkins S, Smyser M, Lafferty W. Survival after AIDS diagnosis in Washington State: Trends through 1989 and effect of the case definition change of 1987. J Acquir Immune Defic Syndr 1993; 6: 1157–1161.
Jacobson L, Kirby A, Polk S, et al. Changes in survival after acquired immunodeficiency syndrome (AIDS): 1984–91. Am J Epidemiol 1993; 138: 952–964.
Osmond D, Charlebois E, Lang W, Shiboski S, Moss A. Changes in AIDS survival time in two San Francisco cohorts of homosexual men, 1983 to 1993. JAMA 1994; 1083–1087.
Saah A, Hoover D, He Y, et al. Factors influencing survival after AIDS: Report from the Multicenter AIDS Cohort Study (MACS). J Acquir Immune Defic Syndr 1994; 7: 287–295.
Lemp G, Payne S, Neal D, Temelso T, Rutherford G. Survival trends for patients with AIDS. JAMA 1990; 263: 402–406.
Lafferty W, Glidden D, Hopkins S. Survival trends of people with AIDS in Washington State. Am J Public Health 1991; 81: 215–218.
Seage G, Oddleifson S, Carr E, et al. Survival with AIDS in Massachusetts, 1979 to 1989. Am J Public Health 1993; 83: 72–78.
Melnick S, Sherer R, Louis T, et al. Survival and disease progression according to gender of patients with HIV infection. JAMA 1994; 272: 1915–1921.
Batalla J, Gatell JM, Caylà JA, et al. Predictors of the survival of AIDS cases in Barcelona, Spain. AIDS 1989; 3: 355–359.
Pedersen C, Gerstolft J, Tauris P, et al. Trends in survival of Danish AIDS patients from 1981 to 1989. AIDS 1990; 4: 1111–1116.
Bindler PJ, Poos RMJ, Jong JT, et al. Trends in mortality of AIDS patients in Amsterdam, 1982–1988. AIDS 1991; 5: 853–858.
Whitmore-Overton SE, Tillett HE, Evans BG, Allardice GM. Improved survival from diagnosis od AIDS adult cases in the United Kingdom and bias due to reporting delays. AIDS 1993; 7: 415–420.
Lundgren J. Pedersen C, Clumeck N, et al. Survival differences in European patients with AIDS, 1979–89. Br Med J 1994; 308: 1068–1073.
Zangerle R, Reibnegger G, Klein JP. Survival differences in Austrian patients with the acquired immunodeficiency syndrome. Eur J Epidemiol 1995; 11: 519–526.
Abeni D, Perucci C. Survival with AIDS, Rome and Latio, 1982–92. Giornale Italiano dell'AIDS 1993: 4: 16–24.
D'Armino Monforte A, Mainini F, Musicco M, et al. Impact of treatment and prophylaxis on presentation and survival of patients with AIDS in Milan. Lancet 1995; 346: 1488.
Center for Disease Control. Revision of the CDC surveillance case definition for acquired immunodeficiency syndrome. MMWR Morb Mortal Wkly Rep 1987; 36: 3S–14S.
Center for Disease Control. 1993 revised classification system for HIV and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Morb Mortal Wkly Rep 1992; 41(RR-17): 1–19.
Vella S, Chiesi A, Vopi A, et al. Differential survival of patients with AIDS according to the 1987 and 1993 CDC case definition. JAMA 1994; 271: 1197–1199.
Harris J. Improved short-term survival of AIDS patients initially diagnosed with Pneumocistis carinii pneumonia, 1984 through 1987. JAMA 1990; 263: 397–401.
Phair J. Effectiveness of zidovudine in treatment of advanced HIV infection. JAMA 1994: 271: 1121–1122.
Clumeck N. Primary prophylaxis against opportunistic infections in patients with AIDS. N Engl J Med 1995; 332: 739–780.
Lundgren J, Phillips A, Pedersen C, et al. Comparison of long-term prognosis of patients with AIDS treated and not treated with zidovudine. JAMA 1994: 271: 1088–1092.
Falhej JL, Taylor JGM, Detels R, et al. The prognostic value of cellular and serologic markes in infection with human immudeficiency virus type 1. N Engl J Med 1990; 322: 166–172.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Barchielli, A., Acciai, S., Lazzeri, V. et al. Survival after AIDS diagnosis in Tuscany (Italy), 1985--1992. Eur J Epidemiol 13, 125–132 (1997). https://doi.org/10.1023/A:1007323722805
Issue Date:
DOI: https://doi.org/10.1023/A:1007323722805